Quantumzyme Corp. (OTC: QTZM), a biotransformation company specializing in enzyme-based solutions for pharmaceutical manufacturing, announced today that it intends to attend the 2026 BIO International Convention, scheduled for June 22–25, 2026, in San Diego, California. The company's representatives expect to participate in informal networking meetings with industry participants but will not present, exhibit, sponsor, or formally engage in conference programming.
The BIO International Convention is a major global gathering for biotechnology and life sciences companies, academic institutions, and industry professionals, covering a wide range of scientific and commercial disciplines. By attending, Quantumzyme aims to connect with peers across the biotechnology and biomanufacturing ecosystem, as stated by CEO Naveen Kulkarni: "Our attendance is focused on listening, learning, and engaging in informal discussions with industry participants as we continue to evaluate developments relevant to our technology and long-term objectives."
This attendance is limited to observation and networking activities, consistent with the company's ongoing efforts to increase industry awareness and maintain dialogue with potential collaborators, technology partners, and other stakeholders. However, there is no assurance that any discussions initiated during the conference will lead to agreements, transactions, or future business relationships. Additional information about the convention can be found at https://convention.bio.org.
Quantumzyme Corp. is a biotransformation company focused on advancing sustainable enzyme-based solutions for pharmaceutical manufacturing. Specializing in green chemistry, the company applies quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support environmentally responsible production. By integrating computational modeling with laboratory validation, Quantumzyme aims to deliver scalable, cost-effective biocatalysis solutions that improve industrial sustainability. For more information, visit www.quantumzymecorp.com and the company's profile at www.otcmarkets.com/stock/QTZM.
The company's decision to attend the BIO International Convention underscores its commitment to staying engaged with industry developments and potential collaborators. As a smaller player in the biotechnology space, Quantumzyme leverages events like BIO to build relationships and gather insights that could inform its long-term strategy. The announcement is significant as it highlights the company's proactive approach to networking and its focus on green chemistry and sustainable manufacturing, which are increasingly important in the pharmaceutical industry.
